Poolbeg Pharma Gets FDA Feedback
Poolbeg Pharma receives FDA feedback on cancer therapy POLB 001, potentially impacting development timeline. This may affect the company's stock price.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.